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Abstract
We conducted a meta-analysis of genome-wide association data to detect genes influencing age at
menarche in 17,510 women. The strongest signal was at 9q31.2 (P = 1.7 × 10−9), where the nearest
genes include TMEM38B, FKTN, FSD1L, TAL2 and ZNF462. The next best signal was near the
LIN28B gene (rs7759938; P = 7.0 × 10−9), which also influences adult height. We provide the first
evidence for common genetic variants influencing female sexual maturation.
Menarche is the start of menstruation and occurs at a mean age of approximately 13 years,
normally about 2 years after the onset of puberty1. Twin and family studies suggest a significant
genetic component to menarcheal age, with at least 50% heritability2–4. Linkage and candidate
gene studies have not confirmed any loci that influence normal variation in age at
menarche4,5. Genome-wide association (GWA) studies have been successful in identifying
many variants associated with complex disease and quantitative traits and we therefore used
this approach to identify genes involved in determining age at menarche. As earlier age at
menarche is associated with shorter stature and obesity, the identified variants may not only
clarify the genetic control of female sexual maturation but may also point to regulatory
mechanisms involved in normal human growth and obesity.
We carried out a meta-analysis of 17,510 females from eight different population-based
cohorts: Age/Gene Environment Susceptibility-Reykjavik Study (AGES-Reykjavik),
Atherosclerosis Risk in Communities (ARIC) Study, Framingham Heart Study (FHS), Amish
HAPI Heart Study, InCHIANTI Study, Rotterdam Study I and II and TWINS UK Study
(Supplementary Note online). Women of European descent, with self-reported age at menarche
between 9 and 17 years (representing the 1st to 99th percentile, with mean age at menarche of
13.12 (s.d. 1.5) years), were included. Agreement between adult-recalled and prospectively
collected age at menarche is reported to be good (κ statistic = 0.81)6. Each study conducted a
GWA analysis using linear regression or linear mixed-effects models with an additive genetic
model adjusting for birth year or birth cohort (FHS), with additional adjustments for population
structure when appropriate. Approximately 2.55 million autosomal SNPs, imputed with
reference to the HapMap CEU panel, passed quality control criteria. We then conducted a meta-
analysis using a fixed-effects model based on inverse variance weighting. Full details of cohorts
and methods are given in Supplementary Table 1 and Supplementary Methods online.
Twenty-eight SNPs passed the conventional genome-wide significance threshold of P < 5 ×
10−8 and were at either 9q31.2 or 6q21 (Supplementary Table 2 and Supplementary Fig. 1
online). The 18 SNPs on chromosome 9 were in linkage disequilibrium (LD), with r2 > 0.31,
as were the 10 SNPs on chromosome 6, with r2 > 0.96 (Fig. 1 and Supplementary Table 2).
To identify more than one signal that could account for the association findings, we carried
out conditional analysis adjusting for the SNP with the lowest P value in the region (rs7759938
for chromosome 6 and rs2090409 for chromosome 9). Within 1 Mb flanking each SNP, the
lowest adjusted P values for association with age at menarche were P = 0.0017 and P = 0.0077
for chromosomes 9 (1,030 SNPs) and 6 (775 SNPs), respectively. These findings suggest a
single signal accounting for the associations at each locus. The quantile-quantile plot
(Supplementary Fig. 2 online) showed modest deviation away from the null when these top
two signals were removed, suggesting the presence of additional loci for this trait.
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The strongest signal at 9q31.2 was observed with rs2090409, where each A allele was
associated with approximately a 5-week reduction in menarcheal age (P = 1.7 × 10−9). All
studies showed consistent evidence of association with the same direction of effect in all but
one study, similar effect sizes and P values between 0.8 and 0.0003 (Table 1). The
recombination region containing rs2090409 includes only a hypothetical gene (BC039487).
Outside of this, the only RefSeq gene within a 1-Mb window is a transmembrane protein gene,
TMEM38B, which is approximately 400 kb proximal to the GWAS signal. In mice,
TMEM38B is expressed strongly in brain and the null mutation is neonatal lethal. Within 2 Mb
of the signal, genes include SLC44A1, FKTN, FSD1L, TAL2 and ZNF462, none of which is an
obvious candidate gene for involvement in menarche. However, a SNP in ZNF462, 650 kb
from our signal but not in LD (r2 = 0.086), has been previously associated with variation in
height6.
The 6q21 signal was within a recombination interval that included only one gene, LIN28B (Fig.
1) and was also associated with approximately a 5-week reduction in menarcheal age per T
allele (rs7759938; P = 7.0 × 10−9). The effect was consistent across all studies, with P values
between 0.27 and 0.001 (Table 1). A common variant in the LIN28B gene has previously been
associated with normal variation in adult height7. The most significant menarche-associated
variant (rs7759938) and the previously reported height variant (rs314277) lie within 28.7 kb
of each other and are likely to represent the same signal, as r2 = 0.26 and D′ = 1 in HapMap.
The allele associated with earlier age at menarche is associated with decreased height, which
is consistent with epidemiological data. Early menarche has been correlated with reduced
stature, and the mechanism is probably mediated through earlier exposure to estrogens resulting
in earlier closure of the epiphyseal plates8. We therefore tested all published common variants
influencing height—44 independent loci—for association with age at menarche in our
dataset9. Six of the alleles were also associated with menarcheal age (P < 0.05), with the
strongest associations at LIN28B (P = 0.0001) and PXMP3 (P = 0.003) (Supplementary Table
3 online). We also tested the association of the newly identified menarche-associated variant,
rs7759938, with measured height in our study population (Supplementary Methods) and found
that it was associated with height, Pmeta = 0.0001, in the same direction in all but one study;
that is, the C allele was associated with reduction in age at menarche and also reduced stature.
The published height SNP (rs314277) did not reach nominal significance with height in our
study (Pmeta = 0.26). These data suggest that some of the previously identified loci that
influence adult height may also have a general role in adolescent growth.
At a given chronologic age, girls with earlier age at menarche tend to have greater body mass
index (BMI) and adiposity than girls with a later age at menarche10–12. A marked secular
decline in age at menarche occurred in Europe in the nineteenth and early twentieth centuries,
which has been attributed to improved nutrition and health1. This trend may be continuing as
a consequence of the obesity epidemic13 and may involve a common metabolic response to
the current nutritional environment14 or be attributable, at least in part, to shared genetic
influences or pleiotropy15. We therefore investigated the effect on menarcheal age of the ten
currently known common gene variants associated with variation in BMI. Of these ten loci,
eight showed an association in the direction consistent with epidemiological data (P = 1.6 ×
10−6, based on Fisher’s combined probability test: −2 × sum(ln P) against χ2 on (10 × 2) df),
and five were nominally significant (P < 0.05) (Supplementary Table 4 online). The two loci
with the largest observed effects on BMI (FTO and TMEM18) also had the strongest evidence
for association with menarcheal age (P = 0.0008 and 7.0 × 10−5, respectively).
This study provides the first evidence for common genetic variants influencing normal
variation in the timing of female sexual maturation. Our findings also indicate a genetic basis
for the phenotypic associations between age at menarche and both height and BMI.
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Genomic context (based on NCBI B36) of the top two independent signals at 9q31.2 and 6q21
plotted against association −log10 P values. Only UCSC Refseq genes are shown. r2 between
each SNP and the top signal is color coded:> 0.8, red; 0.5–0.8, orange; 0.2–0.5, yellow; < 0.2,
unfilled. Blue represents SNP with lowest P value. Chromosome positions are based on build
hg18.
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